［1]TAN PH,ELLIS I,ALLISON K,et al.The 2019 World Health Organization Classification of tumours of the breast［J］.Histopathology,2020,77(2):181-185.
［2]MINAGAWA M,KANZAKI M,TAKANO Y,et al.A case of breast adenocarcinoma changed to squamous cell carcinoma after neoadjuvant chemotherapy［J］.Gan To Kagaku Ryoho,2012,39(7):1111-1114.
［3]ISHIKAWA N,SAIMURA M,KOGA K,et al.A case of metaplastic squamous cell carcinoma of the breast diagnosed after neoadjuvant chemotherapy［J］.Gan To Kagaku Ryoho,2018,45(7):1101-1103.
［4]KONISHI K,ARAYA J,NAGABUCHI M,et al.A case of breast carcinoma that changed subtype to squamous cell carcinoma after chemotherapy［J］.Gan To Kagaku Ryoho,2023,50(7):825-827.
［5]GUO T,CHEN Z,XU J,et al.Change of pathological type to metaplastic squamous cell carcinoma of the breast during disease recurrence:case report and literature review［J］.Frontiers in Oncology,2020,10:32.
［6]INOUE M,KIMURA A,OKA T,et al.Cystic degeneration during neoadjuvant chemotherapy predicts squamous metaplasia of triple negative breast cancer:report of two cases［J］.Int Cancer Conf J,2022,11(4):247-252.
［7]GRAZIANO L,GRAZIANO P FILHO,BITENCOURT AGG,et al.Metaplastic squamous cell carcinoma of the breast:a case report and literature review［J］.Rev Assoc Med Bras (1992),2016,62(7):618-621.
［8]CHEN Z,AN N,ZHANG L,et al.Clinicopathological and therapeutic analysis of primary breast squamous cell carcinoma［J］.Gland Surg,2022,11(1):125-135.
［9]YE XJ,CHEN XY,KE ZB,et al.Sonographic and pathological features of metaplastic squamous cell carcinoma of the breast:a case series［J］.BMC Surg,2021,21(1):374.
［10]EL ZEIN D,HUGHES M,KUMAR S,et al.Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer:a study from a single institution and review of literature［J］.Clin Breast Cancer,2017,17(5):382-391.
［11]VAN DEURZENCH,LEE AH,GILL MS,et al.Metaplastic breast carcinoma:tumour histogenesis or dedifferentiation［J］.J Pathol,2011,224(4):434-437.
［12]BAI R,JIA L,GAO Y,et al.Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC［J］.Thorac Cancer,2022,13(19):2799-2807.
［13]HENNESSY BT,GONZALEZ-ANGULO AM,STEMKE-HALE K,et al.Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics［J］.Cancer Res,2009,69(10):4116-4124.
［14]JUAN LS,FREIJE A,SANZ-GOMEZ N,et al.DNA damage triggers squamous metaplasia in human lung and mammary cells via mitotic checkpoints［J］.Cell Death Discov,2023,9(1):21.
［15]RANA C.Squamous cell carcinoma［EB/OL］.(2022-08-08) ［2023-10-23］Pathology Outlines.comwebsite.https://www.pathology outlines.com/topic/breast malignant scc.html.
［16］刘方方，朱慧庭.乳腺化生性癌 ［J］.现代肿瘤医学，2016,24(17):2805－2807.
LIU FF,ZHU HT.Metaplastic carcinoma of the breast［J］.Modern Oncology，2016,24(17):2805－2807.
［17]CHEN B,JIANG Y,LUO C,et al.Significant efficacy of paclitaxel plus carboplatin (TP) as a neoadjuvant regimen for metaplastic squamous cell carcinoma of the breast:a rare case report and literature review［J］.Transl Cancer Res,2022,11(8):2953-2959.
［18]QI WX,CAO L,XU C,et al.Lumpectomy combined with adjuvant radiotherapy could be a treatment option for primary squamous cell carcinoma of the breast［J］.J Oncol,2021,2021:2497227.
［19]JONEJA U,VRANIC S,SWENSEN J,et al.Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1［J］.J Clin Pathol,2017,70(3):255-259.
［20]LIEN HC,LEE YH,CHEN IC,et al.Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma:implications for distinct immune microenvironments in different metaplastic components［J］.Virchows Arch,2021,478(4):669-678.